1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Preventive Asthma Drugs Market 2015-2019

Global Preventive Asthma Drugs Market 2015-2019

  • October 2015
  • -
  • Infiniti Research Limited
  • -
  • 81 pages

About asthma
According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The symptoms worsen due to the increased secretion of mucus, bronchoconstriction, and thickening of the walls of the airways, resulting in difficulty in expiration. According to the American Academy of Allergy, Asthma, and Immunology, asthma is classified into four types: exercise-induced, allergic, occupational, and childhood. Also, asthma can be classified into two categories: allergic and non-allergic, as per the classification of Asthma and Allergy Foundation of America. Asthma can be managed by preventive medications, which should be administered to the patient regularly to improve his quality of life by controlling the exacerbations.

Technavio's analysts forecast the global preventive asthma drugs market to grow at a CAGR of 5.20% over the period 2014-2019.

Covered in this report
This report covers the present scenario and the growth prospects of the global preventive asthma drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of the following classes of drugs used to treat asthma:
- Immunosuppressants
- Leukotriene antagonists
- Mast cell stabilizers
- Corticosteroids
- Combination of LABA/ ICS

This report includes a discussion of the market in the following three regions:
- Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil
- EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
- APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India

Technavio's report, Global Preventive Asthma Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global preventive asthma drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key Vendors
- AstraZeneca
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Merck
- Novartis

Other prominent vendors
- Abbott
- Amgen
- AptarGroup
- Biotest
- Boehringer Ingelheim
- Chiesi Farmaceutici
- Cytos
- Dainippon Sumitomo
- Medicinova
- Mylan
- Novartis
- Orchid Chemicals and Pharmaceuticals
- Pfizer
- Rottapharm Madaus
- Skyepharma
- Sosei
- Sunovion
- Teva Pharmaceutical
- Theravance
- Vectura

Key market driver
- High prevalence of asthma
- For a full, detailed list, view our report

Key market challenge
- Unknown disease etiology
- For a full, detailed list, view our report

Key market trend
- Growing popularity of combination therapies
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Preventive Asthma Drugs Market 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Product profiles
Accolate
Pulmicort
Symbicort
Xolair
Advair
Anoro Ellipta
Arnuity Ellipta
Breo Ellipta
Flovent
Serevent
Ventolin
Asmanex
Foradil
Dulera
Singulair
PART 06: Disease overview
Understanding the disease
Symptoms
Pathophysiology
Epidemiology
Diagnosis
Management
PART 07: Pipeline Portfolio
PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 09: Market segmentation by class of drug
PART 10: ICS/LABA combination
Global ICS/LABA combination market
PART 11: Immuno-suppressants
Global immunosuppressants market
PART 12: Leukotriene antagonists
Global leukotriene antagonists market
PART 13: Mast cell stabilizers
Global mast cell stabilizers market
PART 14: Inhaled corticosteroids
Global inhaled corticosteroids market
PART 15: Geographical segmentation
Global preventive asthma drugs market by geography 2014-2019
Preventive asthma drugs market in Americas
Preventive asthma drugs market in EMEA
Preventive asthma drugs market in APAC
PART 16: Market drivers
PART 17: Impact of drivers
PART 18: Market challenges
PART 19: Impact of drivers and challenges
PART 20: Market trends
PART 21: Vendor landscape
Competitive scenario
Other and future prominent vendors
PART 22: Key vendor analysis
AstraZeneca
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Novartis
PART 23: Appendix
List of abbreviations
PART 24: Explore Technavio
?

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Major diagnostic procedures for asthma
Exhibit 03: Major drugs under development for asthma
Exhibit 04: Global preventive asthma drugs market ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global preventive asthma drugs market by class of drug
Exhibit 07: Segmentation of global preventive asthma drugs market by class of drug 2014
Exhibit 08: Global preventive asthma drugs market: Market share by class of drug 2014-2019 ($ millions)
Exhibit 09: Global ICS/LABA combination market 2014-2019 ($ millions)
Exhibit 10: Global immunosuppressants market 2014-2019 ($ millions)
Exhibit 11: Global leukotriene antagonists market 2014-2019 ($ millions)
Exhibit 12: Global mast cell stabilizers market 2014-2019 ($ millions)
Exhibit 13: Global corticosteroids market 2014-2019 ($ millions)
Exhibit 14: Global preventive asthma drugs market by geography 2014
Exhibit 15: Global preventive asthma drugs market: Market share by region 2014-2019 ($ millions)
Exhibit 16: Preventive asthma drugs market in Americas 2014-2019 ($ millions)
Exhibit 17: Preventive asthma drugs market in EMEA 2014-2019 ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Sales of Pulmicort in US 2011-2014 ($ millions)
Exhibit 21: Global sales of Pulmicort 2011-2014 ($ millions)
Exhibit 22: AstraZeneca: Key takeaways
Exhibit 23: Sales of Xolair in the US 2011-2014 ($ millions)
Exhibit 24: F. Hoffmann-La Roche: Key takeaways
Exhibit 25: Global sales of Ventolin 2011-2014 ($ millions)
Exhibit 26: Global sales of Flovent 2011-2014 ($ millions)
Exhibit 27: Global sales of Advair 2011-2014 ($ millions)
Exhibit 28: Global sales of Serevent 2011-2014 ($ millions)
Exhibit 29: GlaxoSmithKline: Key takeaways
Exhibit 30: Global sales of Asmanex 2011-2013 ($ millions)
Exhibit 31: Global sales of Dulera 2011-2013 ($ millions)
Exhibit 32: Global sales of Singulair 2011-2013 ($ millions)
Exhibit 33: Merck: Key takeaways
Exhibit 34: Sales of Xolair (ex-US) 2011-2014 ($ millions)
Exhibit 35: Key takeaways: Novartis
Exhibit 36: AstraZeneca: Business segmentation by revenue 2014
Exhibit 37: AstraZeneca: Business segmentation by revenue 2013 and 2014
Exhibit 38: AstraZeneca: Geographical segmentation by revenue 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Albuterol sulfate Market Research Report 2016

Global Albuterol sulfate Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Albuterol sulfate Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Albuterol sulfate industry, focusing on the main regions ...

Global Fudosteine Market Research Report 2016

Global Fudosteine Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Fudosteine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Fudosteine industry, focusing on the main regions (North America, ...

Global Montelukast Market Research Report 2016

Global Montelukast Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Montelukast Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Montelukast industry, focusing on the main regions (North America, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.